|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
gptkb:physician
|
|
gptkbp:age
|
infants 6 to 32 weeks
|
|
gptkbp:approvalYear
|
2006
|
|
gptkbp:approvedBy
|
gptkb:FDA
|
|
gptkbp:ATCCode
|
gptkb:J07BH02
|
|
gptkbp:broadcastOn
|
3-dose series
|
|
gptkbp:contains
|
live attenuated rotavirus
|
|
gptkbp:contraindication
|
gptkb:severe_combined_immunodeficiency_(SCID)
severe allergic reaction to previous dose
history of intussusception
|
|
gptkbp:cost
|
varies by country
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:India
gptkb:Japan
gptkb:United_States
|
|
gptkbp:developedBy
|
gptkb:Merck_&_Co.
|
|
gptkbp:form
|
gptkb:water
oral solution
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
RotaTeq
|
|
gptkbp:includedInNationalImmunizationPrograms
|
many countries
|
|
gptkbp:indication
|
infants
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Merck_&_Co.
2006
|
|
gptkbp:mechanismOfAction
|
induces immunity against rotavirus
|
|
gptkbp:patent
|
gptkb:Merck_&_Co.
|
|
gptkbp:pregnancyCategory
|
Not assigned
|
|
gptkbp:prescriptionRequired
|
true
|
|
gptkbp:prophylactic
|
true
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
fever
vomiting
diarrhea
irritability
intussusception (rare)
|
|
gptkbp:storage
|
2–8°C
|
|
gptkbp:targetPathogen
|
gptkb:rotavirus
|
|
gptkbp:usedFor
|
prevention of rotavirus infection
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:WHOPrequalified
|
true
|
|
gptkbp:bfsParent
|
gptkb:Rotavirus
gptkb:MRK
|
|
gptkbp:bfsLayer
|
5
|